Search

Bijan Ahvazi

Examiner (ID: 16926, Phone: (571)270-3449 , Office: P/1763 )

Most Active Art Unit
1763
Art Unit(s)
1763, 4171, 1761, 1796
Total Applications
1549
Issued Applications
974
Pending Applications
113
Abandoned Applications
482

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6071265 [patent_doc_number] => 20110046116 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'SEDATIVE FOR USE DURING EYE SURGERY' [patent_app_type] => utility [patent_app_number] => 12/858475 [patent_app_country] => US [patent_app_date] => 2010-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 642 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046116.pdf [firstpage_image] =>[orig_patent_app_number] => 12858475 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/858475
SEDATIVE FOR USE DURING EYE SURGERY Aug 17, 2010 Abandoned
Array ( [id] => 5928873 [patent_doc_number] => 20110038832 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE' [patent_app_type] => utility [patent_app_number] => 12/857473 [patent_app_country] => US [patent_app_date] => 2010-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14545 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20110038832.pdf [firstpage_image] =>[orig_patent_app_number] => 12857473 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/857473
METHOD FOR TREATMENT OF MACULAR DEGENERATION USING (+)-2-[1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHYLSULFONYLETHYL]-4-ACETYLAMINOISOINDOLINE-1,3-DIONE Aug 15, 2010 Abandoned
Array ( [id] => 8336458 [patent_doc_number] => 20120203161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-08-09 [patent_title] => 'DEUTERATED WATER AND RIBOFLAVIN SOLUTION FOR EXTENDING SINGLET OXYGEN LIFETIMES IN TREATMENT OF OCULAR TISSUE AND METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 13/390061 [patent_app_country] => US [patent_app_date] => 2010-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4100 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390061 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/390061
DEUTERATED WATER AND RIBOFLAVIN SOLUTION FOR EXTENDING SINGLET OXYGEN LIFETIMES IN TREATMENT OF OCULAR TISSUE AND METHOD OF USE Aug 11, 2010 Abandoned
Array ( [id] => 5929941 [patent_doc_number] => 20110039900 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'ISOTHIOZOLES FOR TREATING CONDITIONS OF THE EYE' [patent_app_type] => utility [patent_app_number] => 12/853914 [patent_app_country] => US [patent_app_date] => 2010-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1196 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039900.pdf [firstpage_image] =>[orig_patent_app_number] => 12853914 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/853914
ISOTHIOZOLES FOR TREATING CONDITIONS OF THE EYE Aug 9, 2010 Abandoned
Array ( [id] => 6215305 [patent_doc_number] => 20110137228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-09 [patent_title] => 'Use of Green Porphyrins to Treat Neovasculature in the Eye' [patent_app_type] => utility [patent_app_number] => 12/849581 [patent_app_country] => US [patent_app_date] => 2010-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6618 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20110137228.pdf [firstpage_image] =>[orig_patent_app_number] => 12849581 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/849581
Use of Green Porphyrins to Treat Neovasculature in the Eye Aug 2, 2010 Abandoned
Array ( [id] => 6196745 [patent_doc_number] => 20110028503 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-03 [patent_title] => 'COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY' [patent_app_type] => utility [patent_app_number] => 12/845655 [patent_app_country] => US [patent_app_date] => 2010-07-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20110028503.pdf [firstpage_image] =>[orig_patent_app_number] => 12845655 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/845655
COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Jul 27, 2010 Abandoned
Array ( [id] => 8196965 [patent_doc_number] => 20120121567 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'OPHTHALMIC SOLUTION FOR PROTECTING INTERNAL STRUCTURES OF THE EYEBALL AGAINST UV-A RAYS OR FOR THE TREATMENT OF KERATOCONUS WITH A TRANS-EPITHELIAL CROSS-LINKING TECHNIQUE' [patent_app_type] => utility [patent_app_number] => 13/387668 [patent_app_country] => US [patent_app_date] => 2010-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 8338 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20120121567.pdf [firstpage_image] =>[orig_patent_app_number] => 13387668 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/387668
Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique Jul 22, 2010 Issued
Array ( [id] => 6637631 [patent_doc_number] => 20100312340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'DL-Lactide-Epsilon-Caprolactone Copolymers' [patent_app_type] => utility [patent_app_number] => 12/841472 [patent_app_country] => US [patent_app_date] => 2010-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5355 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20100312340.pdf [firstpage_image] =>[orig_patent_app_number] => 12841472 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/841472
DL-lactide-ε-caprolactone copolymers Jul 21, 2010 Issued
Array ( [id] => 5929846 [patent_doc_number] => 20110039805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-17 [patent_title] => 'METHOD FOR TREATING MEIBOMIAN GLAND DISEASE' [patent_app_type] => utility [patent_app_number] => 12/841058 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5365 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20110039805.pdf [firstpage_image] =>[orig_patent_app_number] => 12841058 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/841058
METHOD FOR TREATING MEIBOMIAN GLAND DISEASE Jul 20, 2010 Abandoned
Array ( [id] => 6494471 [patent_doc_number] => 20100286010 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-11 [patent_title] => 'Ophthalmic Compositions with Hyaluronic Acid' [patent_app_type] => utility [patent_app_number] => 12/840796 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9585 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0286/20100286010.pdf [firstpage_image] =>[orig_patent_app_number] => 12840796 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/840796
Ophthalmic Compositions with Hyaluronic Acid Jul 20, 2010 Abandoned
Array ( [id] => 6149870 [patent_doc_number] => 20110021465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-27 [patent_title] => 'SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME' [patent_app_type] => utility [patent_app_number] => 12/840396 [patent_app_country] => US [patent_app_date] => 2010-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14032 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20110021465.pdf [firstpage_image] =>[orig_patent_app_number] => 12840396 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/840396
SYNERGISTIC COMPOSITION AND METHOD OF RETARDING AND AMELIORATING PHOTO INDUCED RETINAL DAMAGE AND CATARACTS WHILE AMELIORATING DRY EYE SYNDROME Jul 20, 2010 Abandoned
Array ( [id] => 6113162 [patent_doc_number] => 20110190250 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'EYE DROP WITH DIFLUPREDNATE FOR MACULAR EDEMA TREATMENT' [patent_app_type] => utility [patent_app_number] => 13/122467 [patent_app_country] => US [patent_app_date] => 2010-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5041 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190250.pdf [firstpage_image] =>[orig_patent_app_number] => 13122467 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/122467
EYE DROP WITH DIFLUPREDNATE FOR MACULAR EDEMA TREATMENT Jul 13, 2010 Abandoned
Array ( [id] => 10142446 [patent_doc_number] => 09175249 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-11-03 [patent_title] => 'Ethyleneoxide butyleneoxide block copolymer compositions' [patent_app_type] => utility [patent_app_number] => 12/831890 [patent_app_country] => US [patent_app_date] => 2010-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 5843 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12831890 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/831890
Ethyleneoxide butyleneoxide block copolymer compositions Jul 6, 2010 Issued
Array ( [id] => 6353066 [patent_doc_number] => 20100331430 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-30 [patent_title] => 'PHARMACEUTICAL COMPOSITIONS CONTAINING PROPIONIC PRESERVATIVE COMPONENTS' [patent_app_type] => utility [patent_app_number] => 12/824387 [patent_app_country] => US [patent_app_date] => 2010-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2910 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0331/20100331430.pdf [firstpage_image] =>[orig_patent_app_number] => 12824387 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/824387
PHARMACEUTICAL COMPOSITIONS CONTAINING PROPIONIC PRESERVATIVE COMPONENTS Jun 27, 2010 Abandoned
Array ( [id] => 8173963 [patent_doc_number] => 20120108672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-03 [patent_title] => 'OPHTHALMIC COMPOSITION AND METHOD FOR PREVENTION OF CLOUDINESS/PRECIPITATION' [patent_app_type] => utility [patent_app_number] => 13/380637 [patent_app_country] => US [patent_app_date] => 2010-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9001 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0108/20120108672.pdf [firstpage_image] =>[orig_patent_app_number] => 13380637 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/380637
OPHTHALMIC COMPOSITION AND METHOD FOR PREVENTION OF CLOUDINESS/PRECIPITATION Jun 22, 2010 Abandoned
Array ( [id] => 9401238 [patent_doc_number] => 08691289 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Methods of treating outer eye disorders using high ORP acid water and compositions thereof' [patent_app_type] => utility [patent_app_number] => 12/816731 [patent_app_country] => US [patent_app_date] => 2010-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12584 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12816731 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/816731
Methods of treating outer eye disorders using high ORP acid water and compositions thereof Jun 15, 2010 Issued
Array ( [id] => 6350626 [patent_doc_number] => 20100249134 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-30 [patent_title] => 'Use of Beta-Adrenoceptor Antagonists for the Manufacture of a Medicament for the Treatment of Disorders of the Outer Retina' [patent_app_type] => utility [patent_app_number] => 12/796942 [patent_app_country] => US [patent_app_date] => 2010-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 4795 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20100249134.pdf [firstpage_image] =>[orig_patent_app_number] => 12796942 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/796942
Use of beta-adrenoceptor antagonists for the manufacture of a medicament of the treatment of disorders of the outer retina Jun 8, 2010 Issued
Array ( [id] => 6629982 [patent_doc_number] => 20100311688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-09 [patent_title] => 'OPHTHALMIC FORMULATIONS, METHODS OF MANUFACTURE, AND METHODS OF USING SAME' [patent_app_type] => utility [patent_app_number] => 12/794315 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16737 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20100311688.pdf [firstpage_image] =>[orig_patent_app_number] => 12794315 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/794315
OPHTHALMIC FORMULATIONS, METHODS OF MANUFACTURE, AND METHODS OF USING SAME Jun 3, 2010 Abandoned
Array ( [id] => 10882585 [patent_doc_number] => 08906965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-09 [patent_title] => 'Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation' [patent_app_type] => utility [patent_app_number] => 13/320540 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7341 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13320540 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/320540
Anti-inflammatory quinic acid derivatives for radioprotection/radiomitigation May 10, 2010 Issued
Array ( [id] => 6548170 [patent_doc_number] => 20100222369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'TREATMENT FOR DRY EYE CONDITIONS' [patent_app_type] => utility [patent_app_number] => 12/774927 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6793 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222369.pdf [firstpage_image] =>[orig_patent_app_number] => 12774927 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/774927
TREATMENT FOR DRY EYE CONDITIONS May 5, 2010 Abandoned
Menu